← Open Payments lookup

BAO PHAM: Open Payments

NPI 1417098500 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,187 in 57 payments from 18 companies in 2025. Trend: 2023 $1,145 · 2024 $1,551 · 2025 $1,187

Food & beverage: $1,187
CompanyPaymentsAmount
GlaxoSmithKline, LLC.9$184
Novo Nordisk Inc8$154
AstraZeneca Pharmaceuticals LP4$137
Bayer Healthcare Pharmaceuticals Inc.6$125
Amgen Inc.4$78
Xeris Pharmaceuticals, Inc.4$70
Lilly USA, LLC3$60
Dexcom, Inc.2$60
Exact Sciences Corporation3$54
Gilead Sciences, Inc.2$53

Products named: Kerendia, TRELEGY ELLIPTA, Ozempic, BREZTRI, GVOKE HYPOPEN, MOUNJARO, Dexcom G6 Transmitter, OTEZLA.

Industry payments across TX — which companies pay providers there.